CECLOR
CEFACLOR
Approval overview CECLOR is listed in Drugs@FDA under application 050522 (NDA).
Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFACLOR Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2004-03-17 00:00:00.
Structured Monograph
Clinical summary
Approval overview CECLOR is listed in Drugs@FDA under application 050522 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient CEFACLOR Form and strength FOR SUSPENSION;ORAL - EQ 250MG BASE/5ML **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** Sponsor LILLY Submission history Latest submission status date: 2004-03-17 00:00:00. Submission type: SUPPL.
Monitoring
- • Marketing status: Discontinued
- • Review priority: STANDARD
Interaction Notes
- No interaction notes stored yet.